Sight Sciences sells medical devices for treating glaucoma and dry eye disease, based in Menlo Park, California. SGHT reports earnings on Wed, Nov 4, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 15 | HC Wainwright & Co. | Initiated | Buy | |
| Aug 6 | UBS | Target raised | Buy | |
| Jul 28 | UBS | Assumed coverage | Buy | |
| Jul 8 | Citigroup | Target raised | Hold | |
| May 28 | Citigroup | Maintained | Hold |
Seasonality
How SGHT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in SGHT in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGHT is in one of them and how their past SGHT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SGHT in an article yet. Here's the latest on the wider market.
About Sight Sciences
Sight Sciences is a medical device company based in Menlo Park, California. It sells surgical devices for treating glaucoma, including the OMNI Surgical System and the SION Surgical Instrument, which surgeons use in procedures to lower eye pressure. The company also sells the TearCare system, a device for treating dry eye disease caused by blocked meibomian glands. Its customers are eye care professionals, mainly ophthalmic surgeons and eye doctors, and the patients they treat.
- Headquarters
- Menlo Park, CA